Adicet Bio Inc (ACET) — Capital Reinvestment Ratio

Latest as of March 2022: 0.64x

Adicet Bio Inc (ACET) has a Capital Reinvestment Ratio of 0.64x as of March 2022, meaning it reinvests 1% of its operating cash flow ($4.11 Million) in capital expenditures ($2.63 Million). See cash generation quality of Adicet Bio Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.64x
Capex / Operating Cash Flow

Operating Cash Flow

$4.11 Million
USD

Capital Expenditures

$2.63 Million
USD

Data as of

Mar 2022
Most recent filing

Adicet Bio Inc Capital Reinvestment Ratio (2008–2016)

This chart tracks Adicet Bio Inc's Capital Reinvestment Ratio across 8 annual periods.

Annual Capital Reinvestment Ratio for Adicet Bio Inc (2008–2016)

Year-by-year Capital Reinvestment Ratio for Adicet Bio Inc from 2008 to 2016. For live market cap and broader valuation context, see Adicet Bio Inc (ACET) total market value.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2016 0.07x $8.34 Million $617.00K ▲ +61.8%
2015 0.05x $25.06 Million $1.15 Million ▲ +13.9%
2014 0.04x $25.48 Million $1.02 Million ▼ -6.8%
2013 0.04x $23.73 Million $1.02 Million ▼ -48.0%
2012 0.08x $13.27 Million $1.10 Million ▼ -78.6%
2011 0.39x $14.04 Million $5.42 Million ▲ +1461.8%
2009 0.02x $22.51 Million $557.00K ▼ -68.1%
2008 0.08x $15.42 Million $1.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow